Liaquat National Hospital and Medical College
Karachi, Sindh, Pakistan
NCT Number: NCT06717672
1. *Reduced opioid consumption 2. *Decreased pain scores 3. *Fewer opioid-related side effects 4. *Improved patient satisfaction
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Phase 3
Karachi, Sindh, Pakistan
Studies have shown that lidocaine can reduce opioid consumption by 20-50% in the perioperative period.
Studies have shown that lidocaine can reduce opioid consumption by 20-50% in the perioperative period.
By reducing opioid consumption, lidocaine can also decrease the incidence of opioid-related side effects, such as nausea, vomiting, and respiratory depression.
Lidocaine's analgesic effects can improve patient satisfaction and reduce anxiety related to pain
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Normal saline used is an iv fluid given for fluid replacement
Time frame: at 2 hours, 4 hours, 6 hours
Visual Analog pain scale to rate pain scale comprises 0 to 10 score 0 minimum to 10 Maximum
Liaquat National Hospital & Medical College
Other
Efficacy of Lidocaine in Decreasing Perioperative Analgesic Opioids Requirement After Ambulatory Surgery
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00707057
Neurologic Manifestations, Pain
Salt Lake City, Utah, United States
View Trial DetailsNCT05283980
Acute Pain, Behavior
Boston, Massachusetts, United States
View Trial DetailsNCT02417337
Irreversible Pulpitis, Neurologic Manifestations
Khartoum, Sudan
View Trial DetailsNCT05738239
Neurologic Manifestations, Pain
Hamilton, Ontario, Canada
View Trial Details